CPhI Annual Report

CPHI Annual Report on Pharmaceutical Industry

The 7th edition of the CPHI Annual Survey was unveiled today highlighting trends for 2024. A total of 250 pharmaceutical executives were surveyed with 35 probing questions, with their answers informing the industry landscape for the next year, spanning all major pharma markets.

News • Strategy

Short-Term Reshoring

The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Informa Markets

CPhI Annual Report